Literature DB >> 18162003

Dysmenorrhea in adolescents: diagnosis and treatment.

Linda French1.   

Abstract

Dysmenorrhea occurs in the majority of adolescent girls and is the leading cause of recurrent short-term school absence in this group. In the vast majority of cases, a presumptive diagnosis of primary dysmenorrhea can be made based on a typical history of low anterior pelvic pain coinciding with the onset of menses and lasting 1-3 days with a negative physical examination. Risk factors for primary dysmenorrhea include nulliparity, heavy menstrual flow, and smoking. Poor mental health and social supports are other associations. Empiric therapy for primary dysmenorrhea can be initiated without diagnostic testing. Effective therapies include NSAIDs, oral contraceptives, and pharmacologic suppression of menstrual cycles. In atypical, severe, or refractory cases, imaging and/or laparoscopy should be performed to investigate secondary causes of dysmenorrhea. The most common cause of secondary dysmenorrhea is endometriosis, the treatment of which may include medical and surgical approaches. Pharmacologic treatment of young women with pain related to endometriosis is similar to treatment of primary dysmenorrhea but may infrequently include gonadotropin-releasing hormone agonists in severe refractory cases.

Entities:  

Mesh:

Year:  2008        PMID: 18162003     DOI: 10.2165/00148581-200810010-00001

Source DB:  PubMed          Journal:  Paediatr Drugs        ISSN: 1174-5878            Impact factor:   3.022


  63 in total

Review 1.  Dysmenorrhoea.

Authors:  Michelle Proctor; Cynthia Farquhar
Journal:  Clin Evid       Date:  2003-12

2.  Impact of pregnancy on primary dysmenorrhea.

Authors:  Chi-Mou Juang; Ming-Shien Yen; Nae-Fong Twu; Huann-Cheng Horng; Hung-Chuan Yu; Chih-Yao Chen
Journal:  Int J Gynaecol Obstet       Date:  2006-01-20       Impact factor: 3.561

3.  Factors influencing the prevalence and severity of dysmenorrhoea in young women.

Authors:  G Sundell; I Milsom; B Andersch
Journal:  Br J Obstet Gynaecol       Date:  1990-07

4.  Oral contraceptives for dysmenorrhea in adolescent girls: a randomized trial.

Authors:  Anne Rachel Davis; Carolyn Westhoff; Katharine O'Connell; Nancy Gallagher
Journal:  Obstet Gynecol       Date:  2005-07       Impact factor: 7.661

5.  Effects of aromatase inhibitors on proliferation and apoptosis in eutopic endometrial cell cultures from patients with endometriosis.

Authors:  Gabriela F Meresman; Mariela Bilotas; Verónica Abello; Ricardo Buquet; Marta Tesone; Carlos Sueldo
Journal:  Fertil Steril       Date:  2005-08       Impact factor: 7.329

6.  Menstrual pain, health and behaviour in girls.

Authors:  J Teperi; M Rimpelä
Journal:  Soc Sci Med       Date:  1989       Impact factor: 4.634

7.  Effect of the menstrual cycle and oral contraceptives on cyclooxygenase-2 expression in the endometrium.

Authors:  Hugo Maia; Amélia Maltez; Eduardo Studard; Bela Zausner; Célia Athayde; Elsimar Coutinho
Journal:  Gynecol Endocrinol       Date:  2005-07       Impact factor: 2.260

Review 8.  Danazol for pelvic pain associated with endometriosis.

Authors:  V Selak; C Farquhar; A Prentice; A Singla
Journal:  Cochrane Database Syst Rev       Date:  2001

9.  Comparative study and evaluation of side effects of low-dose contraceptive pills administered by the oral and vaginal route.

Authors:  S Ziaei; L Rajaei; S Faghihzadeh; M Lamyian
Journal:  Contraception       Date:  2002-05       Impact factor: 3.375

10.  Treatment of endometriosis and chronic pelvic pain with letrozole and norethindrone acetate: a pilot study.

Authors:  Radhika K Ailawadi; Smeeta Jobanputra; Meera Kataria; Bilgin Gurates; Serdar E Bulun
Journal:  Fertil Steril       Date:  2004-02       Impact factor: 7.329

View more
  16 in total

1.  Comparative effect of cinnamon and Ibuprofen for treatment of primary dysmenorrhea: a randomized double-blind clinical trial.

Authors:  Molouk Jaafarpour; Masoud Hatefi; Ali Khani; Javaher Khajavikhan
Journal:  J Clin Diagn Res       Date:  2015-04-01

2.  Characterizing the longitudinal relations between depressive and menstrual symptoms in adolescent girls.

Authors:  Sarah J Beal; Lorah D Dorn; Heidi J Sucharew; Lisa Sontag-Padilla; Stephanie Pabst; Jennifer Hillman
Journal:  Psychosom Med       Date:  2014-09       Impact factor: 4.312

3.  Attributes and barriers to care of pelvic pain in university women.

Authors:  Julie Mann; Jonathan Shuster; Nash Moawad
Journal:  J Minim Invasive Gynecol       Date:  2013-08-24       Impact factor: 4.137

Review 4.  Acupuncture for dysmenorrhoea.

Authors:  Caroline A Smith; Mike Armour; Xiaoshu Zhu; Xun Li; Zhi Yong Lu; Jing Song
Journal:  Cochrane Database Syst Rev       Date:  2016-04-18

5.  Morinda citrifolia (Noni) as an Anti-Inflammatory Treatment in Women with Primary Dysmenorrhoea: A Randomised Double-Blind Placebo-Controlled Trial.

Authors:  H M Fletcher; J Dawkins; C Rattray; G Wharfe; M Reid; G Gordon-Strachan
Journal:  Obstet Gynecol Int       Date:  2013-01-29

6.  The impact of a novel herbal Shirazi Thymus Vulgaris on primary dysmenorrhea in comparison to the classical chemical Ibuprofen.

Authors:  Ashraf Direkvand-Moghadam; Afra Khosravi
Journal:  J Res Med Sci       Date:  2012-07       Impact factor: 1.852

7.  Effects of wheat germ extract on the severity and systemic symptoms of primary dysmenorrhea: a randomized controlled clinical trial.

Authors:  Maryam Atallahi; Sedigheh Amir Ali Akbari; Faraz Mojab; Hamid Alavi Majd
Journal:  Iran Red Crescent Med J       Date:  2014-08-05       Impact factor: 0.611

Review 8.  Piroxicam-β-cyclodextrin: a GI safer piroxicam.

Authors:  C Scarpignato
Journal:  Curr Med Chem       Date:  2013       Impact factor: 4.530

9.  Comparison of the pattern, efficacy, and tolerability of self-medicated drugs in primary dysmenorrhea: a questionnaire based survey.

Authors:  Ramya Sugumar; Vasundara Krishnaiah; Gokul Shetty Channaveera; Shilpa Mruthyunjaya
Journal:  Indian J Pharmacol       Date:  2013 Mar-Apr       Impact factor: 1.200

10.  Safety, efficacy and patient acceptability of the combined estrogen and progestin transdermal contraceptive patch: a review.

Authors:  Alessandra Graziottin
Journal:  Patient Prefer Adherence       Date:  2008-02-02       Impact factor: 2.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.